Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Newborn Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Published by Transparency Market Research Product code 1008625
Published Content info 185 Pages
Delivery time: 1-2 business days
Price
Back to Top
Newborn Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
Published: March 9, 2021 Content info: 185 Pages
Description

Scope of the Report

TMR's report on the global newborn screening market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2021 to 2031. The report provides revenue of the global newborn screening market for the period 2017-2031, considering 2019 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global newborn screening market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the newborn screening market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global newborn screening market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global newborn screening market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global newborn screening market.

The report delves into the competition landscape of the global newborn screening market. Key players operating in the global newborn screening market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global newborn screening market profiled in this report.

Key Questions Answered:

  • What is the sales/revenue generated by newborn screening across all regions during the forecast period?
  • What are the opportunities in the global newborn screening market?
  • What are major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which product segment is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What is the market position of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global newborn screening market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global newborn screening market in terms of product, test type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global newborn screening market.

Table of Contents
Product Code: TMRGL4581

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions and Acronyms Used
  • 2.2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunity
  • 4.3. Global Newborn Screening Market Forecast
  • 4.4. Global Newborn Screening Market Outlook

5. Market Outlook

  • 5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
  • 5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
  • 5.3. Overview of the Neonatal Research Funding/Grants

6. Global Newborn Screening Market Analysis, by Product

  • 6.1. Introduction
  • 6.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Product
  • 6.3. Global Newborn Screening Market Forecast, by Product
    • 6.3.1. Instruments
      • 6.3.1.1. Tabletop
      • 6.3.1.2. Point-of-Care Testing
    • 6.3.2. Assay Kits
  • 6.4. Global Newborn Screening Market Analysis, by Product

7. Global Newborn Screening Market Analysis, by Test Type

  • 7.1. Introduction
  • 7.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
  • 7.3. Global Newborn Screening Market Forecast, by Test Type
    • 7.3.1. Dry Blood Spot Test
    • 7.3.2. Hearing Screen Test
    • 7.3.3. Critical Congenital Heart Disease (CCHD) Test
    • 7.3.4. X-ray or CT Scan
    • 7.3.5. Electrocardiogram (ECG) Test
    • 7.3.6. Others
  • 7.4. Global Newborn Screening Market Analysis, by Test Type

8. Global Newborn Screening Market Analysis, by End-user

  • 8.1. Introduction
  • 8.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
  • 8.3. Global Newborn Screening Market Forecast, by End-user
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Centers
    • 8.3.3. Maternity & Specialty Clinics
    • 8.3.4. Others
  • 8.4. Global Newborn Screening Market Analysis, by End-user

9. Global Newborn Screening Market Analysis, by Region

  • 9.1. Global Newborn Screening Market Scenario, by Region/Country
  • 9.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Region
  • 9.3. Global Newborn Screening Market Forecast, by Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa

10. North America Newborn Screening Market Analysis

  • 10.1. North America Newborn Screening Market Overview
  • 10.2. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Country
  • 10.3. North America Newborn Screening Market Forecast, by Country
    • 10.3.1. U.S.
    • 10.3.2. Canada
  • 10.4. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Product
  • 10.5. North America Newborn Screening Market Forecast, by Product
    • 10.5.1. Instruments
      • 10.5.1.1. Tabletop
      • 10.5.1.2. Point-of-Care Testing
    • 10.5.2. Assay Kits
  • 10.6. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
  • 10.7. North America Newborn Screening Market Forecast, by Test Type
    • 10.7.1. Dry Blood Spot Test
    • 10.7.2. Hearing Screen Test
    • 10.7.3. Critical Congenital Heart Disease (CCHD) Test
    • 10.7.4. X-ray or CT Scan
    • 10.7.5. Electrocardiogram (ECG) Test
    • 10.7.6. Others
  • 10.8. North America Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
  • 10.9. North America Newborn Screening Market Forecast, by End-user
    • 10.9.1. Hospitals
    • 10.9.2. Diagnostic Centers
    • 10.9.3. Maternity & Specialty Clinics
    • 10.9.4. Others

11. Europe Newborn Screening Market Analysis

  • 11.1. Europe Newborn Screening Market Overview
  • 11.2. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 11.3. Europe Newborn Screening Market Forecast, by Country/Sub-region
    • 11.3.1. Germany
    • 11.3.2. France
    • 11.3.3. U.K.
    • 11.3.4. Italy
    • 11.3.5. Spain
    • 11.3.6. Rest of Europe
  • 11.4. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Product
  • 11.5. Europe Newborn Screening Market Forecast, by Product
    • 11.5.1. Instruments
      • 11.5.1.1. Tabletop
      • 11.5.1.2. Point-of-Care Testing
    • 11.5.2. Assay Kits
  • 11.6. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
  • 11.7. Europe Newborn Screening Market Forecast, by Test Type
    • 11.7.1. Dry Blood Spot Test
    • 11.7.2. Hearing Screen Test
    • 11.7.3. Critical Congenital Heart Disease (CCHD) Test
    • 11.7.4. X-ray or CT Scan
    • 11.7.5. Electrocardiogram (ECG) Test
    • 11.7.6. Others
  • 11.8. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
  • 11.9. Europe Newborn Screening Market Forecast, by End-user
    • 11.9.1. Hospitals
    • 11.9.2. Diagnostic Centers
    • 11.9.3. Maternity & Specialty Clinics
    • 11.9.4. Others

12. Asia Pacific Newborn Screening Market Analysis

  • 12.1. Asia Pacific Newborn Screening Market Overview
  • 12.2. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 12.3. Asia Pacific Newborn Screening Market Forecast, by Country/Sub-region
    • 12.3.1. Japan
    • 12.3.2. China
    • 12.3.3. India
    • 12.3.4. South Korea
    • 12.3.5. Rest of Asia Pacific
  • 12.4. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Product
  • 12.5. Asia Pacific Newborn Screening Market Forecast, by Product
    • 12.5.1. Instruments
      • 12.5.1.1. Tabletop
      • 12.5.1.2. Point-of-Care Testing
    • 12.5.2. Assay Kits
  • 12.6. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
  • 12.7. Asia Pacific Newborn Screening Market Forecast, by Test Type
    • 12.7.1. Dry Blood Spot Test
    • 12.7.2. Hearing Screen Test
    • 12.7.3. Critical Congenital Heart Disease (CCHD) Test
    • 12.7.4. X-ray or CT Scan
    • 12.7.5. Electrocardiogram (ECG) Test
    • 12.7.6. Others
  • 12.8. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
  • 12.9. Asia Pacific Newborn Screening Market Forecast, by End-user
    • 12.9.1. Hospitals
    • 12.9.2. Diagnostic Centers
    • 12.9.3. Maternity & Specialty Clinics
    • 12.9.4. Others

13. Latin America Newborn Screening Market Analysis

  • 13.1. Latin America Newborn Screening Market Overview
  • 13.2. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 13.3. Latin America Newborn Screening Market Forecast, by Country/Sub-region
    • 13.3.1. Brazil
    • 13.3.2. Mexico
    • 13.3.3. Rest of Latin America
  • 13.4. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Product
  • 13.5. Latin America Newborn Screening Market Forecast, by Product
    • 13.5.1. Instruments
      • 13.5.1.1. Tabletop
      • 13.5.1.2. Point-of-Care Testing
    • 13.5.2. Assay Kits
  • 13.6. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
  • 13.7. Latin America Newborn Screening Market Forecast, by Test Type
    • 13.7.1. Dry Blood Spot Test
    • 13.7.2. Hearing Screen Test
    • 13.7.3. Critical Congenital Heart Disease (CCHD) Test
    • 13.7.4. X-ray or CT Scan
    • 13.7.5. Electrocardiogram (ECG) Test
    • 13.7.6. Others
  • 13.8. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
  • 13.9. Latin America Newborn Screening Market Forecast, by End-user
    • 13.9.1. Hospitals
    • 13.9.2. Diagnostic Centers
    • 13.9.3. Maternity & Specialty Clinics
    • 13.9.4. Others

14. Middle East & Africa Newborn Screening Market Analysis

  • 14.1. Middle East & Africa Newborn Screening Market Overview
  • 14.2. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 14.3. Middle East & Africa Newborn Screening Market Forecast, by Country/Sub-region
    • 14.3.1. GCC Countries
    • 14.3.2. South Africa
    • 14.3.3. Rest of Middle East & Africa
  • 14.4. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Product
  • 14.5. Middle East & Africa Newborn Screening Market Forecast, by Product
    • 14.5.1. Instruments
    • 14.5.2. Tabletop
    • 14.5.3. Point-of-Care Testing
    • 14.5.4. Assay Kits
  • 14.6. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
  • 14.7. Middle East & Africa Newborn Screening Market Forecast, by Test Type
    • 14.7.1. Dry Blood Spot Test
    • 14.7.2. Hearing Screen Test
    • 14.7.3. Critical Congenital Heart Disease (CCHD) Test
    • 14.7.4. X-ray or CT Scan
    • 14.7.5. Electrocardiogram (ECG) Test
    • 14.7.6. Others
  • 14.8. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
  • 14.9. Middle East & Africa Newborn Screening Market Forecast, by End-user
    • 14.9.1. Hospitals
    • 14.9.2. Diagnostic Centers
    • 14.9.3. Maternity & Specialty Clinics
    • 14.9.4. Others

15. Competition Landscape

  • 15.1. Competition Matrix
  • 15.2. Company Share Analysis, 2019
  • 15.3. Company Profiles
    • 15.3.1. PerkinElmer, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Trivitron Healthcare
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Strategic Overview
    • 15.3.3. Natus Medical Incorporated
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Medtronic plc
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Thermo Fisher Scientific, Inc.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Bio-Rad Laboratories, Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. GE Healthcare (General Electric Company)
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. ZenTech S.A.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Strategic Overview
    • 15.3.9. MP BIOMEDICALS
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Strategic Overview
    • 15.3.10. Baebies, Inc.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Strategic Overview
    • 15.3.11. Masimo
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. SWOT Analysis
      • 15.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Newborn Screening Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Newborn Screening Market Value (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 03: Global Newborn Screening Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 04: Global Newborn Screening Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Newborn Screening Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Newborn Screening Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Newborn Screening Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 08: North America Newborn Screening Market Value (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 09: North America Newborn Screening Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 10: North America Newborn Screening Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Newborn Screening Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Newborn Screening Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Europe Newborn Screening Market Value (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 14: Europe Newborn Screening Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 15: Europe Newborn Screening Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Newborn Screening Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Newborn Screening Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 18: Asia Pacific Newborn Screening Market Size (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 19: Asia Pacific Newborn Screening Market Size (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 20: Asia Pacific Newborn Screening Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Newborn Screening Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Newborn Screening Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Latin America Newborn Screening Market Value (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 24: Latin America Newborn Screening Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 25: Latin America Newborn Screening Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 28: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast, by Instruments, 2017-2031
  • Table 29: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 30: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Newborn Screening Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Newborn Screening Market Value Share, by Product, 2019
  • Figure 03: Global Newborn Screening Market Value Share, by End-user, 2019
  • Figure 04: Global Newborn Screening Market Value Share, by Test Type, 2019
  • Figure 05: Global Newborn Screening Market Value Share, by Region, 2019
  • Figure 06: Global Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031
  • Figure 07: Global Newborn Screening Market Revenue (US$ Mn), by Instruments, 2017-2031
  • Figure 08: Global Newborn Screening Market Revenue (US$ Mn), by Assay Kits, 2017-2031
  • Figure 09: Global Newborn Screening Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 10: Global Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031
  • Figure 11: Global Newborn Screening Market Revenue (US$ Mn), by Dry Blood Spot Test, 2017-2031
  • Figure 12: Global Newborn Screening Market Revenue (US$ Mn), by Hearing Screen Test, 2017-2031
  • Figure 13: Global Newborn Screening Market Revenue (US$ Mn), by Critical Congenital Heart Disease (CCHD) Test, 2017-2031
  • Figure 14: Global Newborn Screening Market Revenue (US$ Mn), by X-ray or CT Scan, 2017-2031
  • Figure 15: Global Newborn Screening Market Revenue (US$ Mn), by Electrocardiogram (ECG) Test, 2017-2031
  • Figure 16: Global Newborn Screening Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 17: Global Newborn Screening Market Attractiveness Analysis, by Test Type, 2021-2031
  • Figure 18: Global Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031
  • Figure 19: Global Newborn Screening Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 20: Global Newborn Screening Market Revenue (US$ Mn), by Diagnostic Centers, 2017-2031
  • Figure 21: Global Newborn Screening Market Revenue (US$ Mn), by Maternity & Specialty Clinics, 2017-2031
  • Figure 22: Global Newborn Screening Market Revenue (US$ Mn), by Diagnostic Centers, 2017-2031
  • Figure 23: Global Newborn Screening Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 24: Global Newborn Screening Market Value Share Analysis, by Region, 2019 and 2031
  • Figure 25: Global Newborn Screening Market Analysis, by Region
  • Figure 26: North America Newborn Screening Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 27: North America Newborn Screening Market Value Share (%), by Country, 2019 and 2031
  • Figure 28: North America Newborn Screening Market Attractiveness, by Country, 2021-2031
  • Figure 29: North America Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031
  • Figure 30: North America Newborn Screening Market Attractiveness, by Product, 2021-2031
  • Figure 31: North America Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031
  • Figure 32: North America Newborn Screening Market Attractiveness, by Test Type, 2021-2031
  • Figure 33: North America Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031
  • Figure 34: North America Newborn Screening Market Attractiveness, by End-user, 2021-2031
  • Figure 35: Europe Newborn Screening Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 36: Europe Newborn Screening Market Value Share (%), by Country/Sub-region, 2019 and 2031
  • Figure 37: Europe Newborn Screening Market Attractiveness, by Country/Sub-region, 2021-2031
  • Figure 38: Europe Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031
  • Figure 39: Europe Newborn Screening Market Attractiveness, by Product, 2021-2031
  • Figure 40: Europe Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031
  • Figure 41: Europe Newborn Screening Market Attractiveness, by Test Type, 2021-2031
  • Figure 42: Europe Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031
  • Figure 43: Europe Newborn Screening Market Attractiveness, by End-user, 2021-2031
  • Figure 44: Asia Pacific Newborn Screening Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 45: Asia Pacific Newborn Screening Market Value Share (%), by Country/Sub-region, 2019 and 2031
  • Figure 46: Asia Pacific Newborn Screening Market Attractiveness, by Country/Sub-region, 2021-2031
  • Figure 47: Asia Pacific Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031
  • Figure 48: Asia Pacific Newborn Screening Market Attractiveness, by Product, 2021-2031
  • Figure 49: Asia Pacific Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031
  • Figure 50: Asia Pacific Newborn Screening Market Attractiveness, by Test Type, 2021-2031
  • Figure 51: Asia Pacific Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031
  • Figure 52: Asia Pacific Newborn Screening Market Attractiveness, by End-user, 2021-2031
  • Figure 53: Latin America Newborn Screening Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 54: Latin America Newborn Screening Market Value Share (%), by Country/Sub-region, 2019 and 2031
  • Figure 55: Latin America Newborn Screening Market Attractiveness, by Country/Sub-region, 2021-2031
  • Figure 56: Latin America Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031
  • Figure 57: Latin America Newborn Screening Market Attractiveness, by Product, 2021-2031
  • Figure 58: Latin America Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031
  • Figure 59: Latin America Newborn Screening Market Attractiveness, by Test Type, 2021-2031
  • Figure 60: Latin America Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031
  • Figure 61: Latin America Newborn Screening Market Attractiveness, by End-user, 2021-2031
  • Figure 62: Middle East & Africa Newborn Screening Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 63: Middle East & Africa Newborn Screening Market Value Share (%), by Country/Sub-region, 2019 and 2031
  • Figure 64: Middle East & Africa Newborn Screening Market Attractiveness, by Country/Sub-region, 2021-2031
  • Figure 65: Middle East & Africa Newborn Screening Market Value Share Analysis, by Product, 2019 and 2031
  • Figure 66: Middle East & Africa Newborn Screening Market Attractiveness, by Product, 2021-2031
  • Figure 67: Middle East & Africa Newborn Screening Market Value Share Analysis, by Test Type, 2019 and 2031
  • Figure 68: Middle East & Africa Newborn Screening Market Attractiveness, by Test Type, 2021-2031
  • Figure 69: Middle East & Africa Newborn Screening Market Value Share Analysis, by End-user, 2019 and 2031
  • Figure 70: Middle East & Africa Newborn Screening Market Attractiveness, by End-user, 2021-2031
  • Figure 71: Global Newborn Screening Market Share, by Company, 2019
Back to Top